These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28648520)

  • 1. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
    Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F
    Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
    Dong L; Li Z; Xue L; Li G; Zhang C; Cai Z; Li H; Guo R
    Mol Cell Biochem; 2018 Jan; 438(1-2):183-190. PubMed ID: 28795316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma.
    Duan J; He Y; Fu X; Deng Y; Zheng M; Lu D
    Exp Cell Res; 2018 Sep; 370(2):461-467. PubMed ID: 29981747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
    Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
    Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells.
    Luo X; Liu Y; Ma S; Liu L; Xie R; Li M; Shen P; Wang S
    Gene; 2018 Jul; 662():110-117. PubMed ID: 29596884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
    Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
    J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells.
    Wang C; Ruan P; Zhao Y; Li X; Wang J; Wu X; Liu T; Wang S; Hou J; Li W; Li Q; Li J; Dai F; Fang D; Wang C; Xie S
    Oncotarget; 2017 Jan; 8(1):1092-1109. PubMed ID: 27901475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
    Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
    Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.
    Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y
    Oncotarget; 2016 Mar; 7(12):13575-86. PubMed ID: 26498355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation.
    Fan FT; Shen CS; Tao L; Tian C; Liu ZG; Zhu ZJ; Liu YP; Pei CS; Wu HY; Zhang L; Wang AY; Zheng SZ; Huang SL; Lu Y
    Asian Pac J Cancer Prev; 2014; 15(5):1961-70. PubMed ID: 24716919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDM2B mediates the Wnt/β-catenin pathway through transcriptional activation of PKMYT1 via microRNA-let-7b-5p/EZH2 to affect the development of non-small cell lung cancer.
    Zhang X; Yin Z; Li C; Nie L; Chen K
    Exp Cell Res; 2022 Aug; 417(2):113208. PubMed ID: 35580699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA
    J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
    Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
    Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells.
    Wang Z; Sun P; Gao C; Chen J; Li J; Chen Z; Xu M; Shao J; Zhang Y; Xie J
    Exp Cell Res; 2017 Aug; 357(1):1-8. PubMed ID: 28408316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma.
    Li C; Wu W; Ding H; Li Q; Xie K
    Mol Med Rep; 2018 Jun; 17(6):7645-7651. PubMed ID: 29620186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells.
    Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J
    Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TTYH3/MK5 Positive Feedback Loop regulates Tumor Progression via GSK3-β/β-catenin signaling in HCC.
    Wang Y; Xie Y; Dong B; Xue W; Chen S; Mitsuo S; Zou H; Feng Y; Ma K; Dong Q; Cao J; Zhu C
    Int J Biol Sci; 2022; 18(10):4053-4070. PubMed ID: 35844789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase, membrane‑associated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
    Jeong D; Kim H; Kim D; Ban S; Oh S; Ji S; Kang D; Lee H; Ahn TS; Kim HJ; Bae SB; Lee MS; Kim CJ; Kwon HY; Baek MJ
    Oncol Rep; 2018 Jun; 39(6):2829-2836. PubMed ID: 29658598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling.
    Zhang N; Wang L; Chai ZT; Zhu ZM; Zhu XD; Ma DN; Zhang QB; Zhao YM; Wang M; Ao JY; Ren ZG; Gao DM; Sun HC; Tang ZY
    PLoS One; 2014; 9(12):e115949. PubMed ID: 25542041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.